BR112012033038A2 - composição precursora de diálise - Google Patents

composição precursora de diálise

Info

Publication number
BR112012033038A2
BR112012033038A2 BR112012033038A BR112012033038A BR112012033038A2 BR 112012033038 A2 BR112012033038 A2 BR 112012033038A2 BR 112012033038 A BR112012033038 A BR 112012033038A BR 112012033038 A BR112012033038 A BR 112012033038A BR 112012033038 A2 BR112012033038 A2 BR 112012033038A2
Authority
BR
Brazil
Prior art keywords
precursor composition
dialysis
acid
glucose
dialysis precursor
Prior art date
Application number
BR112012033038A
Other languages
English (en)
Other versions
BR112012033038B1 (pt
Inventor
Anders Wieslander
Lennart Jonsson
Ola Carlsson
Torbjorn Linden
Original Assignee
Gambro Lundia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44513230&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012033038(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gambro Lundia Ab filed Critical Gambro Lundia Ab
Publication of BR112012033038A2 publication Critical patent/BR112012033038A2/pt
Publication of BR112012033038B1 publication Critical patent/BR112012033038B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

composição precursora de diálise. a presente invenção diz respeito a uma composição precursora de diálise de ácido para utilização na preparação de uma solução de concentrado de diálise de ácido e para a msitura com água e um concentrado de bicarbonato contendo uma solução de diálise para pronto-para-uso. a referida composição precursora de diálise de ácido consiste de componentes em pó que compreende cloreto de sódio, pelo menos um ácido seco e pelo menos um sal de magnésio e sal de potássio, opcionalmente, o sal de cálcio, e de glucose. de acordo com a invenção, o referido pelo menos um sal de magnésio e referida gligose glicose opcional, estão presentes como componentes anidros na referida composição precursora de diálise de ácido
BR112012033038-1A 2010-06-23 2011-06-20 Composição precursora de diálise BR112012033038B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE1050686 2010-06-23
SE1050686-3 2010-06-23
US35800810P 2010-06-24 2010-06-24
US61/358,008 2010-06-24
PCT/EP2011/060231 WO2011161055A1 (en) 2010-06-23 2011-06-20 Dialysis precursor composition

Publications (2)

Publication Number Publication Date
BR112012033038A2 true BR112012033038A2 (pt) 2016-12-20
BR112012033038B1 BR112012033038B1 (pt) 2019-10-08

Family

ID=44513230

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012033038-1A BR112012033038B1 (pt) 2010-06-23 2011-06-20 Composição precursora de diálise

Country Status (13)

Country Link
US (1) US10993961B2 (pt)
EP (1) EP2585076B1 (pt)
JP (1) JP5752791B2 (pt)
KR (1) KR101831007B1 (pt)
CN (1) CN102946886B (pt)
AU (1) AU2011269108B2 (pt)
BR (1) BR112012033038B1 (pt)
CA (1) CA2803432C (pt)
ES (1) ES2535867T3 (pt)
HK (1) HK1184703A1 (pt)
PL (1) PL2585076T3 (pt)
TW (1) TWI500424B (pt)
WO (1) WO2011161055A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2585076T3 (pl) 2010-06-23 2015-08-31 Gambro Lundia Ab Kompozycja prekursora do dializy
PL2585039T3 (pl) 2010-06-23 2018-09-28 Gambro Lundia Ab Kompozycja prekursorowa do dializy
FR2975302B1 (fr) 2011-05-18 2013-05-10 Fresenius Medical Care De Gmbh Connecteur pour recipient de dialyse, recipient muni d'un tel connecteur, procede de fabrication et de remplissage de tels connecteurs et recipients
PL2720678T3 (pl) * 2011-06-20 2021-05-04 Gambro Lundia Ab Kompozycja prekursorowa do dializy
PL2720700T3 (pl) 2011-06-20 2016-12-30 Kompozycja prekursorowa do dializy
FR2978914B1 (fr) 2011-08-11 2013-08-16 Fresenius Medical Care De Gmbh Recipient pour dialyse
WO2013092284A1 (en) 2011-12-21 2013-06-27 Gambro Lundia Ab Dialysis precursor composition
AU2012363594B2 (en) 2011-12-21 2014-08-14 Gambro Lundia Ab Dialysis precursor composition
SE536913C2 (sv) 2012-03-08 2014-10-28 Gambro Lundia Ab Komposition för dialys
AU2013201546B2 (en) 2012-12-18 2014-10-23 Gambro Lundia Ab Dialysis composition
WO2014104230A1 (ja) 2012-12-27 2014-07-03 日機装株式会社 透析用剤および透析用剤の製造方法
CN104394857B (zh) 2013-05-08 2018-02-23 甘布罗伦迪亚股份公司 透析制剂
EP2905039A1 (en) * 2014-02-07 2015-08-12 Fresenius Medical Care Deutschland GmbH Dry Acid Concentrate in Granulate form
FR3058893B1 (fr) * 2016-11-21 2019-02-01 Fresenius Medical Care Deutschland Gmbh Procede, installation et reservoir pour fabriquer un concentre acide liquide pour machine d'hemodialyse

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3560380A (en) 1968-10-28 1971-02-02 Mallinckrodt Chemical Works Dry concentrates for preparing hemodialysis solutions
US4756838A (en) 1980-02-21 1988-07-12 Veltman Preston Leonard Preparation of dry dialysate products
CA1241886A (en) 1983-04-13 1988-09-13 Peter W. Field Enema bag
AU627309B2 (en) 1989-05-26 1992-08-20 Terumo Kabushiki Kaisha Preparation for blood dialysis and method for production thereof
JP2749375B2 (ja) * 1989-05-26 1998-05-13 テルモ 株式会社 血液透析用製剤およびその製造方法
JPH0366622A (ja) * 1989-08-07 1991-03-22 Nikkiso Co Ltd 透析液調製方法、透析液調製用剤および透析液調製装置
US5071558A (en) 1989-08-11 1991-12-10 Nikkiso Co., Ltd. Sodium bicarbonate dialysate
ATE137981T1 (de) 1990-12-18 1996-06-15 Univ Washington Dialysat-produktionssystem mit pillen
JPH04257522A (ja) 1991-02-07 1992-09-11 Nikkiso Co Ltd 重曹透析用剤
JP2769592B2 (ja) 1992-12-14 1998-06-25 富田製薬株式会社 重炭酸透析用人工腎臓灌流用剤の製造方法及び人工腎臓灌流用剤
JP3619921B2 (ja) 1996-09-13 2005-02-16 富田製薬株式会社 重炭酸固形透析用剤
FR2766797B1 (fr) 1997-07-30 1999-09-17 Smad Conditionnement pour au moins une matiere solide, notamment sous forme granuleuse ou pulverulente
US7670491B2 (en) 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US6274103B1 (en) 1999-03-26 2001-08-14 Prismedical Corporation Apparatus and method for preparation of a peritoneal dialysis solution
SE9901165D0 (sv) 1999-03-30 1999-03-30 Gambro Lundia Ab Method, apparatus and components of dialysis systems
EP1059083B1 (en) 1999-06-07 2004-04-14 Nipro Corporation A solid pharmaceutical preparation for dialysis and a process for producing the same
WO2001021233A1 (en) 1999-09-22 2001-03-29 Advanced Renal Technologies High citrate dialysate and uses thereof
IT1308861B1 (it) * 1999-11-02 2002-01-11 Gambro Dasco Spa Metodo di controllo di una apparecchiatura di dialisi dedicataall'implementazione della tecnica dialitica afbk e relativa
DE19955578C1 (de) 1999-11-18 2001-09-06 Fresenius Medical Care De Gmbh Mehrkammerbehälter, mit Glucosekonzentratkompartiment und Salzsäurekonzentratkompartiment
JP3899506B2 (ja) 2000-09-27 2007-03-28 ニプロ株式会社 固形透析用製剤およびその製造方法
JP5204359B2 (ja) 2001-09-28 2013-06-05 味の素株式会社 透析用剤およびその製造方法
SE525132C2 (sv) * 2001-11-23 2004-12-07 Gambro Lundia Ab Metod vid manövrering av dialysanordning
US7238164B2 (en) 2002-07-19 2007-07-03 Baxter International Inc. Systems, methods and apparatuses for pumping cassette-based therapies
JP4328851B2 (ja) * 2003-03-03 2009-09-09 富田製薬株式会社 重炭酸固形透析剤
JP4647953B2 (ja) 2003-12-26 2011-03-09 マナック株式会社 一剤型重炭酸透析用固形剤及びその製造方法
JP4760381B2 (ja) 2004-02-09 2011-08-31 ニプロ株式会社 透析用固形製剤およびその製造方法
CN1938058A (zh) * 2004-03-30 2007-03-28 尼普洛株式会社 透析用固体制剂
WO2005094918A1 (ja) 2004-03-30 2005-10-13 Nipro Corporation 透析用固形製剤
MXPA06014608A (es) 2004-06-17 2007-06-12 Stora Enso North America Corp Materiales de empaque de alta proteccion con capas multiples.
US7544301B2 (en) 2004-08-19 2009-06-09 Hhd Llc Citrate-based dialysate chemical formulations
WO2006073164A1 (ja) 2005-01-07 2006-07-13 Ajinomoto Co., Inc. 透析用製剤
RU2311202C1 (ru) 2006-02-08 2007-11-27 Общество С Ограниченной Ответственностью "Нпо "Нефрон" Способ получения кислотного компонента для бикарбонатного гемодиализа
US8133194B2 (en) 2006-02-22 2012-03-13 Henry Ford Health System System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits
KR101467957B1 (ko) 2006-12-12 2014-12-02 아지노모토 가부시키가이샤 철 대사 개선제
TWI419683B (zh) 2007-03-14 2013-12-21 Ajinomoto Kk 骨代謝改善劑
TWI516284B (zh) * 2007-05-31 2016-01-11 味之素股份有限公司 透析用固態製劑
WO2010055963A1 (en) 2008-11-17 2010-05-20 Lee, Jin Tae Manufacturing method of acetate-free dialysate composition
WO2010112570A1 (en) 2009-03-31 2010-10-07 Gambro Lundia Ab Dialysis solution
PL2585039T3 (pl) 2010-06-23 2018-09-28 Gambro Lundia Ab Kompozycja prekursorowa do dializy
PL2585076T3 (pl) 2010-06-23 2015-08-31 Gambro Lundia Ab Kompozycja prekursora do dializy
PL2720700T3 (pl) 2011-06-20 2016-12-30 Kompozycja prekursorowa do dializy
PL2720678T3 (pl) 2011-06-20 2021-05-04 Gambro Lundia Ab Kompozycja prekursorowa do dializy
DE102011106248A1 (de) 2011-07-01 2013-01-03 Fresenius Medical Care Deutschland Gmbh Behälter, Verwendung, Dialysegerät oder Zubereitungseinheit sowie Verfahren zur Herstellung eines Konzentrats

Also Published As

Publication number Publication date
AU2011269108B2 (en) 2014-02-27
JP5752791B2 (ja) 2015-07-22
EP2585076B1 (en) 2015-03-04
CA2803432C (en) 2018-01-16
TW201219040A (en) 2012-05-16
TWI500424B (zh) 2015-09-21
US20130183389A1 (en) 2013-07-18
KR20130041131A (ko) 2013-04-24
US10993961B2 (en) 2021-05-04
WO2011161055A1 (en) 2011-12-29
AU2011269108A1 (en) 2013-02-07
CN102946886A (zh) 2013-02-27
HK1184703A1 (en) 2014-01-30
CA2803432A1 (en) 2011-12-29
KR101831007B1 (ko) 2018-02-21
PL2585076T3 (pl) 2015-08-31
ES2535867T3 (es) 2015-05-18
EP2585076A1 (en) 2013-05-01
JP2013529613A (ja) 2013-07-22
BR112012033038B1 (pt) 2019-10-08
CN102946886B (zh) 2016-01-06

Similar Documents

Publication Publication Date Title
BR112012033038A2 (pt) composição precursora de diálise
BR112012033044A2 (pt) composição de precursor de diálise
CL2013002166A1 (es) Compuesto correspondiente a la sal de magnesio del acido (s)-alfa-etoxi-4-[2-metil-5-[4-metiltiofenil-1h-pirrol-1-il]etoxi]bencenpropanoico; composicion farmaceutica que lo comprende; y uso para el tratamiento de lipodistrofia.
CO6670585A2 (es) Promotores de apotosis n-acilsufonamidas
CL2013000716A1 (es) Un profarmaco o una sal del mismo que comprende un conjugado de exendina-conector; procedimiento de preparacion de dicho profarmaco; compuestos intermediarios; composicion farmaceutica que lo comprende, util para mejorar el control glucemico en pacientes con diabetes de tipo 2.
BR112013020270A2 (pt) derivados de pirazol microbicidas
BR112014000381A2 (pt) processo para a preparação de uma solução aquosa de sais
BR112015021332A2 (pt) sal de sódio de ácido (2s, 5r)-6-benzilóxi-7-oxo-1,6-diaza-biciclo [3.2.1] octano-2-carboxílico e sua preparação
AR081611A1 (es) Combinaciones de principios activos acaricidas y/o insecticidas
BR112015024659A2 (pt) tratamento de diabetes mellitus por formulações de ação prolongada de insulinas
MY169131A (en) Aqueous solutions containing a complexing agent in high concentration
CL2014003189A1 (es) Estabilización química de sal sódica de yodosulfurón-metilo mediante hidroxiestearatos.
BR112015008170A2 (pt) cristal mono-hidratado de sal de potássio fimasartana, método para a preparação do mesmo e composição farmacológica compreendendo o mesmo
BR112016006512A2 (pt) kits de conservação de órgãos, órgão, solução e métodos para preparar solução para conservação de órgãos ou tecidos e tecidos vivos
BR112015011764A2 (pt) composições de baixo teor de sal de sódio e métodos de produção e utilização
CL2012003052A1 (es) Procedimiento para el empobrecimiento de magnesio y el enriquecimiento de litio en soluciones salinas, que comprende adicionar kcl a la solución que se ha de seguir secando por evaporación, el que se transforma con el mgcl2 de la solución en carnalita potasica y se agrega en forma de carnalita potasica.
PH22012000673U1 (en) Anhydrous antiperspirant compositions
BR112016012014A2 (pt) Barra de sabão
GT201300003A (es) Forma cristalina delta de la sal de arginina de perindoprilo, su procedimiento de preparacion , y las composiciones farmacèuticas que la contienen
BR112013003723A2 (pt) concentrado
CL2015001544A1 (es) Método para fabricar sal mineral y producto de sal mineral
EA201300907A1 (ru) Способ борьбы с фитопатогенными грибами
BR112015015327A2 (pt) estabilização de corantes naturais por um pó de acerola
UY34990A (es) Preparación que contiene potasio, proceso para su producción y uso
RU2013141613A (ru) Кардиоплегический раствор "бокерия-болдырева"

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/06/2011, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/06/2011, OBSERVADAS AS CONDICOES LEGAIS